Vascular Surgery - Guideline for Antimicrobial Prophylaxis |
Publication: 14/08/2009 |
Next review: 15/09/2025 |
Clinical Guideline |
CURRENT |
ID: 1677 |
Approved By: Improving Antimicrobial Prescribing Group |
Copyright© Leeds Teaching Hospitals NHS Trust 2022 |
This Clinical Guideline is intended for use by healthcare professionals within Leeds unless otherwise stated. |
GUIDELINE FOR ANTIMICROBIAL PROPHYLAXIS FOR VASCULAR SURGERY
RECOMMENDED ROUTINE PROPHYLAXIS OPTIONS
General comments:
- Where the recommended antibiotic choice in these guidelines does not seem appropriate for a particular patient, for example due to known infection/ colonisation with drug resistant bacteria, the surgeon is advised to discuss antibiotic prophylaxis choice with the Duty Microbiology team pre-operatively.
- Patients already on antibiotic TREATMENT
for infection related to the site of surgery do NOT require additional prophylaxis. If a regular prescribed dose of antibiotic treatment coincides with the timing of the operation ensure that it is administered intra-operatively and not omitted. - Antimicrobial dose/route
Give within 30mins (or up to maximum 1 hour) prior to incision (additional doses may be required1) - Further intra-operative doses
are required of some antibiotics for prolonged procedures or if the patient undergoes total body volume transfusion. For example:- Flucloxacillin
after 4 hours of surgery
- Metronidazole
after 8 hours of surgery.
- Do NOT give another dose Teicoplanin
or Vancomycin
.
- Gentamicin dose can be repeated after 8 hours if patient undergoes total volume transfusion, ensure total daily dose does not exceed 7mg/kg based on ideal body weight.
- Flucloxacillin
Procedure |
Routine |
MRSA Risk2 |
Penicillin allergy |
Arterial surgery including: Aortic surgery Peripheral arterial surgery (except carotid) |
Flucloxacillin |
Teicoplanin |
Teicoplanin |
Post op doses: |
|||
Flucloxacillin |
Teicoplanin |
Teicoplanin |
|
Carotid surgery |
Flucloxacillin |
Teicoplanin |
Teicoplanin |
Amputations (patient NOT already on treatment for infection at site of planned surgery) |
Flucloxacillin |
Teicoplanin |
Teicoplanin |
Post op doses first 24hrs: |
|||
Flucloxacillin |
Teicoplanin |
Teicoplanin |
|
Further post-op doses see note 4 below |
|||
Open Varicose Vein surgery: Recommended only if ulcerated or high risk e.g. morbidly obese |
Flucloxacillin |
Teicoplanin |
Teicoplanin |
Varicose veins: Sclerotherapy or |
Prophylaxis not recommended |
||
A-V fistula formation: Basilic vein transposition and synthetic grafts only |
Teicoplanin |
Teicoplanin |
Teicoplanin |
A-V fistula formation: Radiocephalic or brachiocephalic fistula formation |
Prophylaxis not recommended |
||
Peritoneal dialysis catheter insertion |
Teicoplanin |
Teicoplanin |
Teicoplanin |
Angiogram or angioplasty |
Prophylaxis not recommended |
||
Haemodialysis Line Insertion |
Prophylaxis not recommended |
FOOTNOTES
- Gentamicin dosing should be based on ideal body weight (IBW). Use actual body weight if less than ideal body weight. https://www.mdcalc.com/calc/68/ideal-body-weight-adjusted-body-weight.
- MRSA Risk factors
Patients within these categories are considered at increased risk of MRSA infection:- Known previous infection or colonisation with MRSA at any time.
- Resident of a long term care facility (nursing home, residential home or any other long term residential facility) without a negative MRSA screening result.
- Any history of inpatient hospital stay within the previous 6 months without a negative MRSA screening result
- Teicoplanin and Gentamicin are incompatible; ALWAYS flush between administrations.
- Trans-Metatarsal Amputations (TMAs) and more proximal amputations ONLY:
Post-operative antibiotic prophylaxis may be extended from 24hrs to maximum 5 days post-operatively at the discretion of the responsible vascular consultant.
Regimen: Doxycycline 100mg BD PO + Metronidazole 400mg TDS PO for maximum 4 days.
This is based on a single centre, single blinded randomised trial of 5 days of post-op prophylactic antibiotics for TMA or more proximal amputations demonstrating a significant reduction in surgical site infection and impaired wound healing when compared with 24hrs prophylaxis. There was no impact on length of stay or mortality, and limited data on side effects.
|
Provenance
Record: | 1677 |
Objective: | |
Clinical condition: | Peripheral arterial disease |
Target patient group: | Vascular |
Target professional group(s): | Pharmacists Secondary Care Doctors Secondary Care Nurses |
Adapted from: |
Evidence base
- NICE guidelines [NG125] 2019 Surgical Site Infections: prevention and treatment of surgical site infection
- Global guidelines for the prevention of Surgical Site Infections, second edition. Geneva, World Health Organisation, 2018. Licence: CC BY-NC-SA 3.0 IGO.
- Extended-course antibiotic prophylaxis in lower limb amputation: randomized clinical trial. Souroullas P et al. British Journal of Surgery, 2022, 109, 426-432
Approved By
Improving Antimicrobial Prescribing Group
Document history
LHP version 2.0
Related information
Not supplied
Equity and Diversity
The Leeds Teaching Hospitals NHS Trust is committed to ensuring that the way that we provide services and the way we recruit and treat staff reflects individual needs, promotes equality and does not discriminate unfairly against any particular individual or group.